Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by CerealKilleron Feb 22, 2021 11:13pm
149 Views
Post# 32633960

RE:RE:RE:This is not new ..but an eye opener for SARB and the other

RE:RE:RE:This is not new ..but an eye opener for SARB and the other
maidenmist wrote: So maybe it's time to get out of a stock that's being continually manipulated. I go on record that I will sell my shares after the finaniclas are reported end of April if the  SP stays the same. I;m sure quite a few people on this board will do the same. You said months back, don't compare MEDV to SONA. Well, SONA at least made a massive move to the upside. When do we see OUR massive move???


So, you were advised not to compare MEDV with SONA and then you go ahead and compare MEDV with SONA? You can see the fallacy in that can't you?

You appear to have a sense of entitlement in the sense that you feel you are OWED a massive upswing in share price just because SONA did. Why? Why are you owed this? And why is SONA the one you keep coming back to? To say that they're both COVID plays is a false equivalency since they're doing different things. You could compare MEDV to failed COVID plays and it would be just as (un)reasonable. Heck, you might as well say that GME and AMC and BB all had huge upswings and so you think that MEDV should too (like, nonsensically Hiddensecrets suggested).

Look, MEDV has already gone up a heck of a lot since December. It might and should go up more. But it might not. If you're not comfortable with that prospect, then you should sell, for peace of mind. However, your continued fixation on comparing it with SONA means you're likely never going to be happy, even if it goes up to $5 o $10.
<< Previous
Bullboard Posts
Next >>